OR8G5 Antibody

What is OR8G5 and what is its biological significance?

OR8G5 is a member of the olfactory receptor family involved in odorant detection, contributing to our sense of smell and taste perception. It belongs to the larger family of G-protein-coupled receptors (GPCRs) that contain a 7-transmembrane domain structure. OR8G5 is known for its role in detecting specific odorants and transducing those signals through G protein-mediated pathways . Recent research suggests that olfactory receptors like OR8G5 may also have functions outside the olfactory system, potentially in physiological and pathophysiological processes across various tissues .

What types of OR8G5 antibodies are available for research?

Most commercially available OR8G5 antibodies are:

• Host species: Primarily rabbit-derived

• Clonality: Predominantly polyclonal

• Reactivity: Primarily human, with some showing cross-reactivity with mouse and rat

• Applications: Western blot (WB), ELISA, and immunofluorescence (IF)

• Format: Liquid in PBS containing glycerol, BSA, and sodium azide

Sources typically use synthetic peptides derived from the internal region of human OR8G5 for immunization .

What are the alternative names and associated genes for OR8G5?

When searching literature and databases, researchers should be aware of multiple nomenclatures:

UniProt ID: Q8NG78, Entrez Gene ID: 219865 .

What are optimal protocols for Western blotting with OR8G5 antibodies?

For Western blotting applications:

• Sample preparation: Standard protein extraction from tissues or cells with protease inhibitors

• Protein loading: 20-50 μg of total protein per lane recommended

• Separation: Use 10-12% SDS-PAGE gels (OR8G5 is approximately 36 kDa)

• Transfer: Standard PVDF or nitrocellulose membrane transfer

• Blocking: 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Primary antibody: Dilute OR8G5 antibody 1:500-1:2000 in blocking buffer and incubate overnight at 4°C

• Secondary antibody: Anti-rabbit IgG HRP-conjugated (1:5000-1:10000) for 1 hour at room temperature

• Detection: Standard ECL detection system

To ensure specificity, include positive controls from tissues known to express OR8G5 .

How should OR8G5 antibodies be validated for experimental applications?

Comprehensive validation should include:

• Positive and negative controls: Include tissues/cells known to express OR8G5 (positive) and those that don't (negative)

• Competing peptide assay: Pre-incubation of antibody with the immunizing peptide should abolish signal

• siRNA knockdown: Signal reduction after siRNA-mediated knockdown of OR8G5

• Multiple antibody comparison: Use antibodies from different sources or targeting different epitopes

• Recombinant protein controls: If available, use purified OR8G5 protein as a control

• Western blot band size: Confirm expected molecular weight (approximately 36 kDa)

• Cross-reactivity assessment: Especially important when studying closely related olfactory receptors

These validation steps are crucial for establishing antibody specificity, particularly for olfactory receptors which share sequence homology .

What are appropriate sample preparation methods for immunofluorescence studies?

For immunofluorescence applications with OR8G5 antibodies:

• Fixation: 4% paraformaldehyde for 15-20 minutes at room temperature

• Permeabilization: 0.1-0.3% Triton X-100 in PBS for 10 minutes

• Blocking: 5-10% normal serum (from the species of secondary antibody) with 1% BSA for 1 hour

• Primary antibody: Dilute OR8G5 antibody 1:200-1:1000 in blocking buffer, incubate overnight at 4°C

• Secondary antibody: Fluorophore-conjugated anti-rabbit IgG at 1:500-1:1000 for 1 hour at room temperature

• Counterstaining: DAPI for nuclear staining

• Mounting: Anti-fade mounting medium to preserve fluorescence

For membrane proteins like OR8G5, mild permeabilization is critical to maintain epitope accessibility while preserving membrane structure .

How is OR8G5 expression characterized across normal human tissues?

OR8G5 shows differential expression across human tissues:

• Primarily expressed in: Olfactory epithelium (canonical location)

• Low expression in: Epstein-Barr virus-transformed lymphocytes (RPKM: 1.5), testis (RPKM: 0.4), prostate (RPKM: 0.3), spleen (RPKM: 0.3), and whole blood (RPKM: 0.3)

• Minimal to undetectable in: Most other tissues, including normal breast tissue

This tissue distribution suggests potential functions beyond olfaction. Research from the GTEx database shows that OR8G5 expression is highly tissue-specific, with most healthy tissues showing median RPKM values near zero .

What is known about OR8G5's potential role as a cancer biomarker?

Emerging research suggests OR8G5 may have relevance as a cancer biomarker:

• Breast cancer: Studies demonstrate increased expression of OR2B6 in breast carcinoma tissues compared to normal breast tissue, with OR8G5 among the studied olfactory receptors

• Brain tumors: Interestingly, while several ORs (including OR2B6) show expression in cancerous brain tissues, OR8G5 specifically has been detected in certain brain tumor samples but not in healthy brain tissue

• Pancreatic cancer: Research has shown OR4C6 and other olfactory receptors including OR8G5 to be expressed in pancreatic carcinoma samples but not in normal pancreatic tissue

These findings suggest ectopic expression of OR8G5 may be associated with neoplastic transformation, potentially serving as a diagnostic or prognostic marker .

How might OR8G5 be involved in non-histocompatibility antigen mismatching?

Studies examining non-histocompatibility antigen mismatching have identified OR8G5 as a gene of interest:

• Transplant rejection: OR8G5 has been identified among olfactory transduction factor genes (along with OR51F1 and OR8G1) that show variant mismatches between donor and recipient in kidney transplantation studies

• eQTL mapping: These variants map to expression quantitative trait loci (eQTLs) in blood vessels for genes like VWA5A (von Willebrand factor A domain-containing protein 5A)

• Functional significance: While olfactory receptors might initially seem irrelevant to transplant outcomes, their variants may modify downstream genes that impact vascular function and transplant survival

• Antibody-mediated rejection: The variants associated with these genes appear to be enriched in patients who develop antibody-mediated rejection (AMR) after transplantation

This research suggests OR8G5 may have previously unrecognized roles in immunological processes relevant to organ transplantation .

What are common challenges when using OR8G5 antibodies and how can they be addressed?

Researchers frequently encounter these issues when working with OR8G5 antibodies:

These issues often arise due to the high sequence homology among olfactory receptors and their typically low expression levels in non-olfactory tissues .

How can OR8G5 expression be quantified in research samples?

Multiple approaches can quantify OR8G5 expression:

• Western blot densitometry:

  • Capture images using a digital imaging system

  • Use software like ImageJ to perform densitometric analysis

  • Normalize to loading controls (β-actin, GAPDH)

  • Compare relative expression between samples

• qRT-PCR analysis:

  • Design primers specific to OR8G5 (avoiding homologous regions with other ORs)

  • Use SYBR Green or TaqMan-based detection systems

  • Employ the 2^(-ΔΔCT) method for relative quantification

  • Normalize to established housekeeping genes (e.g., GAPDH, ACTB)

• RNA-Seq analysis:

  • Measure expression in FPKM/RPKM values

  • Compare with databases like GTEx for tissue-specific baselines

  • Validate findings with qRT-PCR

• Immunohistochemistry scoring:

  • Use H-score method (intensity × percentage of positive cells)

  • Employ digital pathology platforms for quantification

  • Compare with established scoring systems

Each method has advantages for different experimental contexts. Integration of multiple approaches provides the most reliable quantification .

What is known about OR8G5's function beyond olfactory perception?

Emerging research suggests olfactory receptors like OR8G5 may have physiological functions beyond smell perception:

• Cancer biology: Expression in breast, pancreatic, and brain cancer tissues suggests potential roles in cancer development or progression

• Immune system interactions: Association with non-histocompatibility antigen mismatching in organ transplantation indicates possible immunological functions

• Cellular signaling: As a GPCR, OR8G5 likely activates G protein-mediated signaling cascades in non-olfactory contexts

• Tissue-specific expression: Low but detectable expression in lymphocytes, testis, spleen, and blood suggests potential functions in these tissues

Recent studies on ectopically expressed ORs show they can participate in physiological and pathophysiological cell processes outside their canonical olfactory roles .

How are new technologies advancing OR8G5 research?

Innovative approaches are expanding our understanding of OR8G5:

• Single-cell RNA sequencing:

  • Reveals cell type-specific expression patterns

  • Identifies rare cell populations expressing OR8G5

  • Maps developmental and disease-related expression changes

• CRISPR-Cas9 gene editing:

  • Enables precise knockout/knockin models

  • Facilitates investigation of OR8G5 function

  • Allows tagging of endogenous protein for localization studies

• Advanced structural biology:

  • Cryo-EM and computational modeling of OR8G5 structure

  • Prediction of ligand binding sites

  • Rational design of specific modulators

• High-throughput agonist screening:

  • Identification of synthetic and natural ligands

  • Development of reporter assays for functional studies

  • Characterization of signaling pathways

• Metabolomics integration:

  • Identification of endogenous ligands

  • Mapping of metabolic pathways influenced by OR8G5

  • Correlation with physiological functions

These technological advances promise to reveal new insights about OR8G5's biological roles beyond olfaction .

What therapeutic applications might target OR8G5 in the future?

Potential therapeutic applications targeting OR8G5 include:

• Cancer diagnostics and treatment:

  • If confirmed as a cancer biomarker, OR8G5 detection could aid diagnosis

  • Antibody-drug conjugates targeting OR8G5-expressing tumors

  • Development of small-molecule antagonists to inhibit potential oncogenic signaling

• Transplant medicine:

  • Screening for OR8G5 variants to predict rejection risk

  • Immunomodulatory approaches targeting OR8G5-mediated responses

  • Personalized immunosuppression strategies based on variant profiles

• Sensory modulation:

  • Targeting OR8G5 for anosmia or dysgeusia treatment

  • Development of novel fragrance compounds

  • Appetite regulation through olfactory modulation

• Drug delivery systems:

  • Nanobodies or antibody fragments targeting OR8G5

  • Tissue-specific drug delivery using OR8G5 binding ligands

  • Repurposing existing OR ligands for therapeutic purposes

These potential applications remain largely theoretical pending further research into OR8G5's physiological roles and validation of its disease associations .